FDA revises MAPPs on data standards program, scientific interest groups
Regulatory NewsJoanne S. Eglovitch
North AmericaPharmaceuticalsRegulatory Intelligence/PolicyRegulatory NewsJoanne S. EglovitchNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy